
Shanghai Immunocan Biotech Co., Ltd.
Shanghai, China · immunocan.com
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Shanghai Immunocan Biotech Co., Ltd. builds antibody drug discovery platforms using gene-edited animals. It serves global antibody drug R&D through licensing and collaborative research, with work centered in Shanghai, China.
Their website has a general contact form; we send your quote request through it.
What they offer
ImmuMab® Mouse licensing
Licenses the ImmuMab® Mouse fully human antibody discovery platform for antibody drug discovery.
Collaborative research
Provides collaborative research support for antibody discovery programs.
Create new animals
Develops new gene-edited animals for antibody generation and related discovery applications.
MASIRT® platform development
Uses Massive-fragment Across Species In situ Replacement Technology (MASIRT®) to replace DNA fragments across species for creating new in vivo antibody-generating animals.
What they work on
- Modalities
- Antibody, Bispecific, ADC
- Species and models
- mouse, rabbit, alpaca
- Scale and capacity
- megabase-scale DNA fragment replacement, three months to replace Mb-scale gene fragment
- Sites
- Shanghai, China
- Serves
- global
- Address
- 398 Xinlai Rd. Jiading district,Shanghai,CHINA
- Founded
- 2020
Similar labs. AbTherx, Biocytogen, Biointron, Invenra
Found in a contract services directory. Listing built from immunocan.com. Work here? Claim this listing.